3 Ultra-Risky Robinhood Stocks That Just Might Make You a Fortune

By Motley Fool

In August, iBio (NYSEMKT: IBIO) announced encouraging preclinical results for experimental COVID-19 vaccine IBIO-201. In addition, iBio licensed a COVID-19 therapeutic candidate, ACE2-Fc, from Planet Biotechnology. If the company's COVID-19 vaccine and/or its therapeutic candidate go on to deliver great results in clinical testing, though, the biotech stock could soar a lot higher than its year-to-date gain of more than 580%.

…read more

Via:: Sports Headlines

      

Get 20% off hat purchases for ONLY $5! Join our LIDS Club @ lids.com.
%d bloggers like this: